Cited by 48Alzheimer's disease research and treatmentsParkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease

Open access
Reich, Niklas, Hölscher, Christian·2020·Frontiers in Neuroscience

Abstract

Much thought has been given to the impact of Amyloid Beta, Tau and Alpha-Synuclein in the development of Alzheimer's disease (AD) and Parkinson's disease (PD), yet the clinical failures of the recent decades indicate that there are further pathological mechanisms at work. Indeed, besides amyloids, AD and PD are characterized by the culminative interplay of oxidative stress, mitochondrial dysfunction and hyperfission, defective autophagy and mitophagy, systemic inflammation, BBB and vascular damage, demyelination, cerebral insulin resistance, the loss of dopamine production in PD, impaired neurogenesis and, of course, widespread axonal, synaptic and neuronal degeneration that leads to cognitive and motor impediments. Interestingly, the acylated form of the hormone ghrelin has shown the potential to ameliorate the latter pathologic changes, although some studies indicate a few complications that need to be considered in the long-term administration of the hormone. As such, this review will illustrate the wide-ranging neuroprotective properties of acylated ghrelin and critically evaluate the hormone's therapeutic benefits for the treatment of AD and PD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnins.2020.614828

Cites

464 of 464 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

12 of the 476 references couldn’t be matched to a known paper.

Research works printed but not linked: 10

  1. Berti V. C. Polito P. Borghammer S. Ramat L. Mosconi E. Vanzi M. T.. (2012). Alternative normalization methods demonstrate widespread cortical hypometabolism in untreated de novo Parkinson's disease. Q. J. Nuclear Med. Mol. Imag. 56, 299– 308. Available online at: https://www.minervamedica.it/en/journals/nuclear-med-molecular-imaging/article.php?cod=R39Y2012N03A0299 22695340 PMC3846292
  2. Fang W. Y. Qu X. K. Yuan F. Wang W. G. Fei J.. (2013). AMPK activity is down-regulated in endothelial cells of GHS-R−/− mice. Int. J. Clin. Exp. Pathol. 6, 1770– 1780. Available online at: http://europepmc.org/article/PMC/3759483 24040441 PMC3759483
  3. Jerlhag E. Egecioglu E. Dickson S. L. Engel J. A. (2010). Ghrelin receptor antagonism attenuates cocaine- and amphetamine-induced locomotor stimulation, accumbal dopamine release, and conditioned place preference. Psychopharmacology 211, 415– 422. 10.1007/s00213-010-1907-7 20559820 PMC2908453 · DOI
  4. Konturek P. C. Brzozowski T. Engel M. Burnat G. Gaca P. Kwiecien S.. (2009). Ghrelin ameliorates colonic inflammation. role of nitric oxide and sensory nerves. J. Physiol. Pharmacol. 60, 41– 47. 19617644
  5. Kutty B. M. Subramanian S. (2014). Amyloid beta lowering and cognition enhancing effects of ghrelin receptor analog [D-Lys (3)] GHRP-6 in rat model of obesity. Biochem. Biophys. 51, 257– 262. Available online at: https://www.semanticscholar.org/paper/Amyloid-beta-lowering-and-cognition-enhancing-of-in-Madhavadas-Kutty/709c2106abfeee0d1d6c8477b8ded7e630ad0997?p2df 25296496
  6. Majumder S. Richardson A. Strong R. Oddo S. (2011). Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits. PLoS ONE 6: e25416. 10.1371/journal.pone.0025416 21980451 PMC3182203 · DOI
  7. Mao Y. Q. Cheng J. Yu F. J. Li H. Q. Guo C. Y. Fan X. N. (2015). Ghrelin attenuated lipotoxicity via autophagy induction and nuclear factor-kappa B inhibition. Cell. Physiol. Biochem. 37, 563– 576. 10.1159/000430377 26329041 · DOI
  8. Poewe W. Seppi K. Tanner C. M. Halliday G. M. Brundin P. Volkmann J. (2017). Parkinson disease. Nat. Rev. Dis. Primers 3: 17013 10.1038/nrdp.2017.13 28332488 · DOI · Paper page
  9. Yokochi M. (2007). Mesolimbic and mesocortical pathways in parkinson disease. Brain Nerve 59, 943– 951. 10.11477/mf.1416100129 17886476 · DOI
  10. Zhang X. Zhang G. Zhang H. Karin M. Bai H. Cai D. (2008). Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 135, 61– 73. 10.1016/j.cell.2008.07.043 18854155 PMC2586330 · DOI · Paper page

Cited by

Sorted by citations

Authors
Reich, N., & Hölscher, C.
Affiliations
  • Lancaster University (GB)
  • Henan University of Chinese Medicine (CN)
Corresponding author
Reich, Niklas
Venue
Frontiers in Neuroscience
Published
2020-12-14
Volume
14
Pages
614828-614828
ISSN
1662-453X (ISSN-L)
OpenAlex
W3111850577
Cited by
48
References
476
Citations by year
2026: 7 · 2025: 6 · 2024: 7 · 2023: 9 · 2022: 13 · 2021: 6
FWCI
0.92
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Neuroscience (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Lancaster EPrints (Lancaster University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
acylated ghrelin, Alzheimer's disease, Parkinson's disease, neuroprotection, oxidative stress, mitochondrial dysfunction, autophagy, mitophagy, systemic inflammation, blood-brain barrier, dopamine depletion, neurogenesis, multi-target therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review